| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO And Interim CEO
1 company
Smith Hunter C is a Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 33 sells.
Estimated insider holdings value: $10.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 7,954 | $101.31 | $805,813.76 | -0.8% | -12.1% | - | |
| Feb 12, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 7,071 | $100.21 | $708,575.59 | -0.6% | -2.4% | - | |
| Aug 13, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 28,088 | $96.29 | $2,704,623.77 | -10.7% | +2.0% | - | |
| Jul 9, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 42,120 | $80.48 | $3,389,756.13 | -9.5% | +12.2% | - | |
| May 30, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 23,400 | $61.41 | $1,437,010.37 | -8.9% | +69.9% | +44.0% | |
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 2,215 | $57.22 | $126,742.30 | -2.0% | +10.1% | +77.9% | |
| Feb 12, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 751 | $56.39 | $42,346.85 | -0.4% | -1.5% | +66.7% | |
| Feb 11, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,296 | $57.51 | $74,533.06 | -0.6% | +2.4% | +71.0% | |
| Feb 4, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 1,678 | $59.43 | $99,723.54 | -1.6% | +7.4% | +80.1% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 15,515 | $39.22 | $608,498.30 | -13.7% | +5.2% | +41.1% |